Latest Observability News

Right Resources has significantly enlarged its Blue tungsten prospect near Tumbarumba, NSW, confirming strong geochemical signatures and advancing metallurgical testwork to assess recovery potential.

Elixir Energy has successfully completed a key pressure test on its Lorelle-3H well in Queensland’s Taroom Trough, confirming reservoir conditions and increasing planned stimulation stages from 11 to 12. Stimulation operations are set to start imminently, aiming to prove commercial gas and condensate flow.

Galilee Energy has begun site preparation for its Zydeco-1 well in Louisiana, on track for a July 2026 spud targeting up to 8 billion cubic feet of gas and 0.5 million barrels of condensate.

BPM Minerals has confirmed a significant down-dip extension of high-grade gold mineralisation at its Beachcomber Main Lode within the Forelands Gold Project, Western Australia, with assays showing continuity over 300m strike and 250m vertical depth.

Evolution Energy Minerals (ASX:EV1) is set to launch its maiden drilling campaign at Tanzania's Chikundo Copper Project, targeting multiple high-confidence copper anomalies defined by recent soil sampling and historical data.

Solstice Minerals has pushed the known limits of its Nanadie Copper-Gold Project with Phase 2 drilling confirming mineralisation 160m beyond the 2022 resource boundary and over a 1.2km strike length. The ongoing campaign includes diamond tails probing depth extensions, with assays pending to quantify promising visual sulphide zones.

Southern Hemisphere Mining has pushed visible copper sulphide mineralisation deeper at its Llahuin project in Chile, with diamond drilling confirming continuity down to 256 metres. Assay results are pending, setting the stage for a clearer picture of the system’s scale and grade.

Imugene’s off-the-shelf CAR T therapy azer-cel has won FDA Fast Track Designation for relapsed or refractory CLL/SLL and MZL, backed by compelling Phase 1b response rates.

Strata Minerals has validated a significant gold mineralised system along a 9.5km corridor at its Zelica South Project in Western Australia, with rock chip samples hitting up to 11.78 g/t Au and silver anomalies supporting a fertile hydrothermal system.

Nimy Resources has identified a 16km gold anomaly corridor at its Mons Project in Western Australia, including the new Corporate James prospect, and is preparing a drill program to test these promising targets.

LTR Pharma has secured a binding US telehealth commercialisation framework for its intranasal erectile dysfunction treatment ROXUS, committing to at least 150,000 prescriptions in the first year and granting exclusivity to Shed Holdings' platform.

Southern Hemisphere Mining has confirmed extensive visible copper sulphide mineralisation down to 256 metres in diamond drilling at its Llahuin project, underpinning the scale potential of this porphyry copper system.